Abstract
To determine whether microcrystalline hydroxyapatite compound (MCHC) could reduce bone loss or its consequences in patients with chronic active hepatitis (CAH) on corticosteroid therapy, a controlled trial was conducted in 36 such patients over a period of 2 years. Both skeletal symptoms (back pain) and fractures were uncommon during the trial period but both showed non-significant differences in favour of the MCHC group and biochemical investigations were suggestive of a reduction in parathyroid over-activity. Continued reduction in bone mineral content of the radius (photon absorptiometry) was halted in those receiving MCHC and iliac crest bone biopsy showed a non-significant increase in trabecular bone volume. The fall in iliac crest cortical plate thickness was significantly less (P less than 0.025) in the MCHC group and the results overall were consistent with a beneficial effect from MCHC in corticosteroid-induced osteoporosis.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Briancon D., Meunier P. J. Treatment of osteoporosis with fluoride, calcium, and vitamin D. Orthop Clin North Am. 1981 Jul;12(3):629–648. [PubMed] [Google Scholar]
- Dent C. E., Davies I. J. Calcium metabolism in bone disease: effects of treatment with microcrystalline calcium hydroxyapatite compound and dihydrotachysterol. J R Soc Med. 1980 Nov;73(11):780–785. doi: 10.1177/014107688007301106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Epstein O., Kato Y., Dick R., Sherlock S. Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosis. Am J Clin Nutr. 1982 Sep;36(3):426–430. doi: 10.1093/ajcn/36.3.426. [DOI] [PubMed] [Google Scholar]
- Kato Y., Epstein O., Dick R., Sherlock S. Radiological patterns of cortical bone modelling in women with chronic liver disease. Clin Radiol. 1982 May 3;33(3):313–317. doi: 10.1016/s0009-9260(82)80276-6. [DOI] [PubMed] [Google Scholar]
- Nillson B. E., Westlin N. E. The bone mineral content in the forearm of women with colles' fracture. Acta Orthop Scand. 1974;45(6):836–844. doi: 10.3109/17453677408989694. [DOI] [PubMed] [Google Scholar]
- Pines A., Raafat H., Lynn A. H., Whittington J. Clinical trial of microcrystalline hydroxyapatite compound ('Ossopan') in the prevention of osteoporosis due to corticosteroid therapy. Curr Med Res Opin. 1984;8(10):734–742. doi: 10.1185/03007998409110124. [DOI] [PubMed] [Google Scholar]
- Vedi S., Compston J. E., Webb A., Tighe J. R. Histomorphometric analysis of bone biopsies from the iliac crest of normal British subjects. Metab Bone Dis Relat Res. 1982;4(4):231–236. doi: 10.1016/0221-8747(82)90032-7. [DOI] [PubMed] [Google Scholar]
- Wootton R., Reeve J. The relative merits of various techniques for measuring radiocalcium absorption. Clin Sci (Lond) 1980 Apr;58(4):287–293. doi: 10.1042/cs0580287. [DOI] [PubMed] [Google Scholar]
